MedTrace Logo

Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women

NCT06827704 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2025-07-24

No results posted yet for this study

Summary

This study aims to to improve physical activity and metabolic outcomes for breast cancer prevention in South Asian Indian immigrant women.

Conditions

  • Metabolic Syndrome
  • Breast Cancer Prevention
  • Physical Activity

Interventions

BEHAVIORAL

Enhanced physical activity monitor which is Fitbit watch with mobile App

Participants will receive an enhanced physical activity monitor treatment for 6 months which includes goal setting with a physical activity prescription, and self-monitoring with a physical activity monitor (Fitbit watch). Edit

BEHAVIORAL

Bollywood-style group dance

Participants will participate in 60-minute, moderate-intensity Bollywood-style culturally tailored group dance virtual sessions, 2x/week for 6 months

BEHAVIORAL

PAMDance

Participants will receive an enhanced physical activity monitor treatment for 6 months which includes goal setting with a physical activity prescription, and self-monitoring with a physical activity monitor (Fitbit watch). In addition, Participants will participate in 60-minute, moderate-intensity Bollywood-style culturally tailored group dance virtual sessions, 2x/week for 6 months

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Manju Daniel, PhD · Rush University College of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06827704 on ClinicalTrials.gov